(untitled)

Hallvard Holdaas, Bengt Fellström, Ingar Holme, Gudrun Nyberg, Per Fauchald, Alan G. Jardine, Carola Grönhagen‐Riska, Sören Madsen, Hans‐Hellmut Neumayer, Edward Cole, Bart Meas, Thomas Weinreich, Anders Olsson, Terje Pedersen, Renée Benghozi, Anders Hartmann, on behalf of the ALERT Study Group

Journal of Cardiovascular Risk

April 1, 2001

10.1097/00043798-200104000-00002

Cited by 32

Abstract

Related Papers

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

James Shepherd, Stuart M. Cobbe, Ian Ford et al.|New England Journal of Medicine|1995|7.5k

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group|New England Journal of Medicine|1998|5.3k

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

John R. Downs, Michael Clearfield, Stephen E. Weis et al.|JAMA|1998|5.3k

Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White Men

James D. Neaton|Archives of Internal Medicine|1992|784

Cardiovascular disease after renal transplantation.

B L Kasiske, Carlos Guijarro, Ziad A. Massy et al.|Journal of the American Society of Nephrology|1996|673